ETF Managers Group’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $311K | Sell |
723,151
-787,721
| -52% | -$339K | 0.01% | 531 |
|
|
2022
Q4 | $801K | Sell |
1,510,872
-748,098
| -33% | -$396K | 0.04% | 189 |
|
|
2022
Q3 | $1.65M | Sell |
2,258,970
-188,437
| -8% | -$138K | 0.05% | 165 |
|
|
2022
Q2 | $2.82M | Sell |
2,447,407
-1,214,935
| -33% | -$1.4M | 0.08% | 145 |
|
|
2022
Q1 | $7.87M | Sell |
3,662,342
-923,399
| -20% | -$1.99M | 0.16% | 124 |
|
|
2021
Q4 | $13.3M | Buy |
4,585,741
+121,967
| +3% | +$355K | 0.26% | 110 |
|
|
2021
Q3 | $18.7M | Sell |
4,463,774
-115,506
| -3% | -$485K | 0.35% | 89 |
|
|
2021
Q2 | $24.8M | Buy |
4,579,280
+2,591,494
| +130% | +$14M | 0.4% | 86 |
|
|
2021
Q1 | $9.24M | Buy |
1,987,786
+173,458
| +10% | +$807K | 0.16% | 126 |
|
|
2020
Q4 | $5.99M | Buy |
1,814,328
+923,303
| +104% | +$3.05M | 0.13% | 120 |
|
|
2020
Q3 | $2.95M | Sell |
891,025
-350,571
| -28% | -$1.16M | 0.09% | 136 |
|
|
2020
Q2 | $4.18M | Buy |
1,241,596
+33,470
| +3% | +$113K | 0.15% | 109 |
|
|
2020
Q1 | $4.63M | Sell |
1,208,126
-828,404
| -41% | -$3.17M | 0.21% | 94 |
|
|
2019
Q4 | $12.3M | Sell |
2,036,530
-642,927
| -24% | -$3.88M | 0.43% | 83 |
|
|
2019
Q3 | $20.3M | Buy |
2,679,457
+441,614
| +20% | +$3.34M | 0.73% | 45 |
|
|
2019
Q2 | $30.3M | Buy |
+2,237,843
| New | +$30.3M | 0.97% | 40 |
|